EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin

Amanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, Sven-Erik Strand, Bo Åkerström, Anders Örbom

Scientific Reports · 2024

DOI: 10.1038/s41598-024-61370-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Amanda Kristiansson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences Lund, Section for Oncology, Lund University, Barngatan 4, 222 42, Lund, Sweden. Hauptthemen laut MEDLINE: Alpha-Globulins, Dipeptides, Heterocyclic Compounds, 1-Ring, Lutetium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Crafoordska Stiftelsen, Fru Berta Kamprads Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radioligand therapy with [ 177 Lu]Lu-PSMA-617 can be used to prolong life and reduce tumor burden in terminally ill castration resistant prostate cancer patients. Still, accumulation in healthy tissue limits the activity that can be administered. Therefore, fractionated therapy is used to lower toxicity. However, there might be a need to reduce toxicity even further with e.g. radioprotectors. The aim of this study was to (i). establish a preclinical mouse model with fractionated high activity therapy of three consecutive doses of 200 MBq [ 177 Lu]Lu-PSMA-617 in which we aimed to (ii). achieve measurable hematotoxicity and nephrotoxicity and to (iii). analyze the potential protective effect of co-injecting recombinant α 1 -microglobulin (rA1M), a human antioxidant previously shown to have radioprotective effects. In both groups, three cycles resulted in increased albuminuria for each cycle, with large individual variation. Another marker of kidney injury, serum blood urea nitrogen (BUN), was only significantly increased compared to control animals after the third cycle. The number of white and red blood cells decreased significantly and did not reach the levels of control animals during the experiment. rA1M did reduce absorbed dose to kidney but did not show significant protection here, but future studies are warranted due to the recent clinical studies showing a significant renoprotective effect in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alpha-GlobulinsDipeptidesHeterocyclic Compounds, 1-RingLutetiumAnimalsHumansMiceBlood Urea NitrogenKidneyProstate-Specific AntigenProstatic Neoplasms, Castration-ResistantRadiopharmaceuticals

Substanzen

alpha-1-microglobulinAlpha-GlobulinsDipeptidesHeterocyclic Compounds, 1-RingLutetiumPluvictoProstate-Specific AntigenPSMA-617Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Clinical Sciences Lund, Section for Oncology, Lund University, Barngatan 4, 222 42, Lund, Sweden.
  • Department of Clinical Sciences Lund, Section for Pediatrics, Lund University, Lund, Sweden.
  • Department of Neonatology, Skåne University Hospital, Lund, Sweden.
  • Department of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
  • Department of Clinical Sciences Lund, Section for Medical Radiation Physics, Lund University, Lund, Sweden.
  • Department of Clinical Sciences Lund, Section for Infection Medicine, Lund University, Lund, Sweden.

Förderung

  • Cancerfonden
  • Crafoordska Stiftelsen
  • Fru Berta Kamprads Stiftelse
  • Lund University

Zitieren

APA

Kristiansson, A., Vilhelmsson Timmermand, O., Altai, M., Strand, S. E., Åkerström, B., & Örbom, A. (2024). Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin. Scientific Reports. https://doi.org/10.1038/s41598-024-61370-2

Vancouver

Kristiansson A, Vilhelmsson Timmermand O, Altai M, Strand SE, Åkerström B, Örbom A. Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin. Scientific Reports. 2024. doi:10.1038/s41598-024-61370-2

BibTeX
@article{Kristiansson2024,
  author = {Kristiansson, Amanda and Vilhelmsson Timmermand, Oskar and Altai, Mohamed and Strand, Sven-Erik and Åkerström, Bo and Örbom, Anders},
  title = {Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin},
  journal = {Scientific Reports},
  year = {2024},
  doi = {10.1038/s41598-024-61370-2}
}
Kostenlos starten →